Kimberly J. Popovits

Insider Reports History

Entity
Individual
Location
301 Penobscot Drive, Redwood City, California
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Kimberly J. Popovits
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kimberly J. Popovits:

Stock Role Class Num Shares Value Price $ Report Date Ownership
10x Genomics, Inc. Director Class A Common Stock 13.3 K $322 K $24.30 Jun 11, 2024 Direct
Kiniksa Pharmaceuticals, Ltd. Director Class A Common Share 9.37 K $168 K $17.88 Jun 6, 2024 Direct
Talis Biomedical Corp Director Stock option (right to buy) 95 K Jun 9, 2023 Direct
Kiniksa Pharmaceuticals, Ltd. Director Share Option 19 K Jun 5, 2024 Direct
10x Genomics, Inc. Director Stock Option (right to buy) 4.66 K Jun 14, 2023 Direct
Kiniksa Pharmaceuticals, Ltd. Director Restricted Share Units 0 Jun 6, 2024 Direct

Insider Reports Filed by Kimberly J. Popovits

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TXG 10x Genomics, Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 5, 2024 4 $0 4 Jun 7, 2024 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2023 2 $0 4 Jul 3, 2023 Director
TXG 10x Genomics, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
TLIS Talis Biomedical Corp Jun 9, 2023 1 $0 4 Jun 12, 2023 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 6, 2023 2 $0 4 Jun 8, 2023 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2022 2 $0 4 Jun 30, 2022 Director
TXG 10x Genomics, Inc. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
TLIS Talis Biomedical Corp Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
TLIS Talis Biomedical Corp Aug 30, 2021 1 $0 4 Aug 31, 2021 Interim CEO
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2021 1 $0 4 Jun 30, 2021 Director
TXG 10x Genomics, Inc. Jun 11, 2021 2 $0 4 Jun 15, 2021 Director